Page 29 - IMR ANNUAL REPORT 2021: INSTITUTE FOR MEDICAL RESEARCH
P. 29
16 IMR ANNUAL REPORT 2021
Prevalence of HPV Associated Dr Hans
12 Oropharyngeal Squamous Cell NMRR-20-49-52574 Prakash A/L
Carcinoma (OPSCC) in Malaysia Sathasivam
Study of Regulatory Function of miRNA
13 NMRR-19-2148-48481 Dr Ezalia Esa
for Precision Medicine in AML
Multi-centre Clinico-Pathological Dr Hans
Study of Malaysian Patients with NMRR-20-2550-57039
14
Prakash
CANCER RESEARCH CENTRE (CaRC) 15 Hepatocellular Carcinoma (HCC) NMRR-21-629-59503 Sathasivam
Prevalence of Human Papillomavirus
Dr Hans
(HPV) - Associated Head and Neck
Prakash
Squamous Cell Carcinoma (HNSCC) in
Malaysia Sathasivam
Characterisation of Spatial Dr Hans
Relationships Between Tumour and
16 NMRR-21-580-59388 Prakash
Immune cells in the Microenvironment Sathasivam
of Nasopharyngeal Carcinoma
Epigenetic Alterations in Malaysia
Primary Acute Myeloid Leukaemia Nor Rizan
17 NMRR-20-3013-57079
(AML) Patients: Prognosis and Kamaluddin
Treatment
MicroRNA-mRNA regulatory
relationship in Normal Karyotype Acute Co-PI: Dr Ezalia
18 Myeloid Leukaemia (NK-AML) assessed IMR - UM Collaboration Esa & Dr Yuslina
by human clinical and computational Mat Yusoff
data.
Chromosome aberrations in
interventional radiology staff Ruzanaz Syafira
19 NMRR-18-230-40243
occupationally exposed to low dose Ruzman Azlee
ionizing radiation
Plasma-Based Glycoproteomic Studies
20 on Nasopharyngeal Carcinoma (NPC) NMRR-19-2435-50208 Dr Tan Lu Ping
in Malaysia Population
Comprehensive Genomic Profiling of
21 NMRR-20-3214-57318 Dr Tan Lu Ping
Epithelial Ovarian Cancer
Whole Exome Sequencing (WES) of
Early Death in Malaysian Subcohort
22 NMRR-21-684-59379 Dr Tan Lu Ping
in LifeCare with Metabolic Syndrome
(MetS)
Whole Exome Sequencing of
23 Childhood Interstitial Lung Disease in NMRR-20-1187-53192 Dr Tan Lu Ping
Malaysia
Circulating Tumour Cells for the
24 NMRR-21-359-58705 Dr Tan Lu Ping
Prognosis of Breast Cancer
Biodistribution Study of Cytopeutics
Human Umbilical Cord Mesenchymal Low Chui
25 NMRR-21-643-59215
Stem Cells (hUC-MSC) by Intravenous Thean
Administration Route in BALB/c mice